Trading in Calliditas’ share commences today on Nasdaq Stockholm

June 29, 2018

Calliditas Therapeutics AB (publ) today announces the outcome of the offering of new shares in the Company and the listing of the Company’s share on Nasdaq Stockholm. The SEK 650 million offering was substantially over-subscribed, attracting strong interest from local and international institutional investors as well as the general public in Sweden.   Read the full press release on Calliditas’ website.

By continuing on the site you accept our terms and conditions for cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.